Acetoacetyl-CoA Thiolase Deficiency

Acetoacetyl-CoA thiolase deficiency is a rare, inherited metabolic disease. The body lacks enough activity of an enzyme called mitochondrial acetoacetyl-CoA thiolase (also called T2, encoded by the ACAT1 gene). This enzyme is important for breaking down the amino acid isoleucine and for using ketone bodies as fuel. When this enzyme does not work well, harmful acids build up in the blood, causing repeated attacks of ketoacidosis with vomiting, dehydration, deep breathing, confusion, and sometimes coma—often during illness, fasting, or other stress. Many children appear well between attacks if they avoid triggers. Lifelong prevention focuses on avoiding prolonged fasting, early glucose during illness, and fast treatment of acidosis. PubMed Central+2MedlinePlus+2

The condition is autosomal recessive. Babies inherit a faulty ACAT1 gene from each parent. Diagnosis relies on clinical features, blood gases showing metabolic acidosis, and urine organic acids that show isoleucine-derived metabolites (like 2-methyl-3-hydroxybutyrate and tiglylglycine). Genetic testing of ACAT1 confirms the diagnosis. Many different disease-causing variants have been reported worldwide. PubMed Central+2PubMed+2

Acetoacetyl-CoA thiolase deficiency is a rare, inherited metabolic disorder. A small “worker” protein (an enzyme) in your cell’s mitochondria—called mitochondrial acetoacetyl-CoA thiolase, also known as β-ketothiolase or “T2”—doesn’t work properly. Because of this, the body struggles to handle two jobs: breaking down the amino acid isoleucine (a building block of protein) and using ketone bodies for energy when you’re sick, fasting, or not eating enough carbohydrates. The result is a tendency to have sudden “metabolic crises” with ketoacidosis (acid buildup with high ketones), especially in infancy or early childhood. Between attacks, many people feel completely well. The disorder is autosomal recessive, meaning a child is affected when they inherit a non-working copy of the ACAT1 gene from each parent. MedlinePlus+1

During attacks, the safe and proven approach is high-rate glucose infusion to stop ketone production and careful correction of acidosis and electrolytes. Between attacks, families use a “sick-day plan” that starts oral glucose early, keeps the child well hydrated, and seeks medical help for persistent vomiting or fast breathing. Some centers also use carnitine supplementation when levels are low. orpha.net+1

During an acute episode, blood and urine show a characteristic pattern of organic acids and acylcarnitines related to blocked isoleucine breakdown and ketone use. Typical markers in urine are 2-methyl-3-hydroxybutyrate, tiglylglycine, and sometimes the unstable 2-methylacetoacetate; blood acylcarnitines can show C5:1 (tiglyl-carnitine) and C5-OH (2-methyl-3-hydroxybutyryl-carnitine), though these can be normal even during a crisis. Orpha+2Access Pediatrics+2

Other names

You can find many names for the same condition in articles and lab reports. All of the following usually refer to the same disease:

• β-ketothiolase deficiency

• 3-ketothiolase deficiency

• 2-methylacetoacetyl-CoA thiolase deficiency (MAT deficiency / MATD)

• Acetoacetyl-CoA thiolase deficiency

• Mitochondrial acetoacetyl-CoA thiolase (T2) deficiency

• 3-oxothiolase deficiency

• Alpha-methylacetoacetic aciduria

• 2-methyl-3-hydroxybutyric acidemia (historical; note this name can also appear in a different disorder—HSD10 disease—so modern sources prefer “β-ketothiolase deficiency”). Biomedres+1

---

Types

1) Typical infant-to-toddler episodic form.
Most children present between 2 months and 2 years (median about 12 months) with sudden vomiting, fast breathing, and drowsiness during an illness or fasting. They recover with treatment and can be well between attacks. BioMed Central

2) Neonatal-onset severe form (uncommon).
A small minority present in the newborn period with severe acidosis and encephalopathy. This is rare compared with the typical form. BioMed Central

3) Intermittent/benign course.
With early diagnosis and prevention, many individuals have normal development and few or no crises; long-term outcome is often favorable compared with other organic acidemias. BioMed Central

4) Late-childhood/adult presentations (rare).
Occasionally, diagnosis occurs later, sometimes after a “metabolic stroke” picture or even alongside other conditions (e.g., diabetes with ketoacidosis reported in an adult). PubMed+1

5) Imaging-led presentations.
Some patients show basal ganglia (striatal) changes on MRI, sometimes independent of obvious ketoacidosis, and not always tied to symptoms. BioMed Central

---

Causes

Core cause (genetic): The disease itself happens when both copies of the ACAT1 gene have pathogenic variants, reducing or abolishing β-ketothiolase activity. Different variant types (missense, nonsense, frameshift, splice) have been reported across many populations. There is no clear genotype–phenotype correlation; even siblings can differ in severity. MedlinePlus+1

Below are 20 plain-language “causes” grouped as root genetic factors and attack triggers (things that bring on episodes in someone who has ACAT1 deficiency):

1. Autosomal-recessive ACAT1 variants—inheriting two non-working copies from carrier parents. MedlinePlus

2. Loss-of-function missense changes—enzyme made but works poorly. BioMed Central

3. Truncating (nonsense/frameshift) variants—short, nonfunctional enzyme. BioMed Central

4. Splice-site variants—enzyme built incorrectly due to faulty RNA splicing. BioMed Central

5. Population-specific variants—for example, p.Arg208* described more often in some regions. BioMed Central

6. Consanguinity/family history—increases chance both parents carry the same variant. BioMed Central

Triggers of metabolic crises in affected individuals:

7. Fasting or skipped feeds—low carbs push the body to rely on ketones, which it can’t use well. rarediseases.info.nih.gov

8. Infections/fever—raise energy demand and catabolism. rarediseases.info.nih.gov

9. High protein (isoleucine-rich) load—adds more substrate the pathway can’t handle. rarediseases.info.nih.gov

10. Dehydration/vomiting—concentrates acids and worsens acidosis. rarediseases.info.nih.gov

11. Prolonged strenuous exercise while under-fueled—simulates fasting stress. BioMed Central

12. Surgery or anesthesia without proper glucose support—catabolic stress. BioMed Central

13. Crash dieting/ketogenic dieting—drives ketone production the body can’t use. BioMed Central

14. Long overnight fasts in toddlers—common real-world trigger. BioMed Central

15. Intercurrent illnesses (gastroenteritis)—combine poor intake and catabolism. rarediseases.info.nih.gov

16. Poor access to early carbohydrates during illness—delay in “sick-day” carbs. BioMed Central

17. Fever-related enzyme instability—higher temperatures may stress marginal enzyme function (conceptual). BioMed Central

18. Unrecognized diagnosis—first crisis may be most dangerous without specific care. BioMed Central

19. Low carnitine stores—sometimes present in organic acidemias and may worsen energy handling (not universal). BioMed Central

20. Mistaken management (e.g., delayed glucose in ED)—allows ketones and acids to rise. BioMed Central

---

Symptoms

1. Vomiting—often the first sign of a crisis during an illness. rarediseases.info.nih.gov

2. Extreme tiredness (lethargy)—low usable energy to the brain. rarediseases.info.nih.gov

3. Fast, deep breathing (Kussmaul respirations)—the body tries to blow off acid. rarediseases.info.nih.gov

4. Dehydration—from vomiting and rapid breathing. rarediseases.info.nih.gov

5. Seizures—can occur during severe acidosis. rarediseases.info.nih.gov

6. Confusion or reduced consciousness—acid buildup affects the brain. rarediseases.info.nih.gov

7. Fruity/acetone breath odor—sign of high ketones. Biomedres

8. Poor feeding in infants—especially during minor illnesses. BioMed Central

9. Rapid heartbeat—stress response to acidosis and dehydration. BioMed Central

10. Abdominal pain—can accompany vomiting and acidosis. BioMed Central

11. Development typically normal between episodes—many children do well outside crises. BioMed Central

12. “Metabolic stroke” symptoms—acute weakness/movement problems in some cases. PubMed

13. Movement disorders (e.g., chorea/athetosis or hypotonia)—reported during/after crises. Biomedres

14. Breathing difficulty—from acidosis and dehydration. rarediseases.info.nih.gov

15. Coma in severe, untreated episodes—a medical emergency. rarediseases.info.nih.gov

---

Diagnostic tests

A) Physical examination (bedside observations)

1. General appearance and vital signs.
   Doctors look for fever, rapid breathing, fast heart rate, and signs of shock—clues to acidosis and dehydration. rarediseases.info.nih.gov

2. Hydration status.
   Dry mouth, poor skin turgor, sunken eyes/fontanelle in infants point to dehydration that worsens acid buildup. rarediseases.info.nih.gov

3. Neurologic exam.
   Level of alertness, seizures, abnormal movements help judge how the brain is affected during a crisis and guide urgent care. rarediseases.info.nih.gov

4. Respiratory pattern.
   Deep, fast breathing suggests metabolic acidosis and is an immediate red flag. rarediseases.info.nih.gov

5. Growth and development check (between episodes).
   Many children grow and develop normally, which can help distinguish this disorder from others that cause constant symptoms. BioMed Central

B) “Manual” / near-patient tests (quick checks)

6. Urine ketone dipstick.
   A simple strip that turns positive with high ketones—expected in crises here. It’s fast but not specific to this disorder. rarediseases.info.nih.gov

7. Capillary glucose.
   Finger-stick sugar level helps detect hypoglycemia (may be normal or low in crises). It guides immediate treatment. BioMed Central

8. Point-of-care blood gas.
   A quick bedside test that shows low bicarbonate and acidic pH in metabolic acidosis. rarediseases.info.nih.gov

9. Serum/whole-blood β-hydroxybutyrate.
   A rapid meter (where available) estimates ketone level to confirm ketosis. BioMed Central

10. Temperature measurement.
    Fever is a common trigger; documenting it supports the clinical picture and guides care. rarediseases.info.nih.gov

C) Laboratory & pathological tests (confirm and define)

11. Comprehensive metabolic panel and electrolytes.
    Looks for low bicarbonate, an anion-gap acidosis, and electrolyte shifts seen in vomiting and dehydration. rarediseases.info.nih.gov

12. Ammonia and lactate.
    Can be elevated in metabolic illnesses and help rule in/out other causes of encephalopathy alongside this diagnosis. BioMed Central

13. Urine organic acids by GC-MS (key test).
    Shows a characteristic pattern: 2-methyl-3-hydroxybutyrate and tiglylglycine, sometimes 2-methylacetoacetate (unstable), confirming blockage in isoleucine breakdown. Orpha

14. Plasma acylcarnitine profile (MS/MS).
    May show C5:1 and C5-OH elevations—but importantly, these can be normal even during a crisis, so a normal result does not exclude the disease. Access Pediatrics+1

15. Enzyme assay in fibroblasts/lymphocytes.
    Measures β-ketothiolase activity directly; reduced activity supports the diagnosis (fibroblasts are more reliable). BioMed Central

16. Molecular genetic testing of ACAT1.
    Confirms pathogenic variants; helpful for family counseling and avoiding misdiagnosis with look-alike disorders. MedlinePlus

17. Newborn screening (where available).
    Some programs flag C5-OH/C5:1, but screening can miss cases; clinical vigilance remains essential. newbornscreening.hrsa.gov+1

18. Carnitine (free and total).
    Assesses carnitine status, which may be low in some organic acidemias and is sometimes supplemented in care plans. BioMed Central

19. Differential testing to rule out HSD10 disease.
    Because urine 2-methyl-3-hydroxybutyrate can also increase in HSD17B10 (HSD10) disease, genetic confirmation avoids confusion. BioMed Central

20. Full blood count and liver panel.
    Useful for overall status and to exclude other causes of illness that can mimic or accompany a crisis. BioMed Central

D) Electrodiagnostic tests

21. EEG (electroencephalogram).
    If seizures occur, EEG helps confirm and guide treatment; seizures typically relate to acute metabolic stress. rarediseases.info.nih.gov

22. ECG (electrocardiogram).
    Severe electrolyte changes from vomiting and acidosis can affect the heart rhythm; ECG safety-checks are often done in emergencies. BioMed Central

E) Imaging tests

23. Brain MRI.
    May show basal ganglia/striatal injury during or after severe crises; imaging findings do not always match symptoms. BioMed Central

24. Head CT (acute settings).
    Used when MRI isn’t immediately available to exclude other acute causes in a lethargic or seizing child. BioMed Central

25. Abdominal ultrasound.
    Looks for liver enlargement or other complications during a prolonged illness. BioMed Central

26. Chest X-ray (if breathing symptoms).
    Screens for pneumonia/aspiration during a crisis, which can worsen acidosis. BioMed Central

Note on prognosis: With early recognition, sick-day plans (avoiding fasting, giving extra carbohydrates during illness), and routine follow-up, many children have good outcomes, and a large international review found the condition relatively benign compared with many other organic acidemias. The first, unrecognized crisis carries the highest risk—so awareness matters. BioMed Central

---

Non-pharmacological treatments (therapies and other measures)

1. Sick-day glucose plan at home
   A written sick-day plan teaches caregivers to start frequent oral glucose (e.g., glucose polymer solutions, sweetened fluids) at the first sign of illness—before vomiting becomes severe. The goal is to prevent catabolism (the body breaking down fat and protein) that triggers ketone overproduction. Families are instructed to monitor for fast breathing, lethargy, and poor intake, and to seek care early for IV support. Clear instructions reduce emergency visits and complications.
   Purpose: Prevent metabolic decompensation during minor illnesses.
   Mechanism: Exogenous glucose raises insulin and suppresses lipolysis and ketogenesis, reducing acid production. orpha.net

2. Avoidance of prolonged fasting
   Daily routines minimize long gaps between meals and add a bedtime carbohydrate snack. During intercurrent illness, fasting should be avoided entirely; if oral intake is poor, families escalate to medical care for IV dextrose. This prevention step is one of the strongest protective measures.
   Purpose: Reduce risk of ketoacidosis.
   Mechanism: Continuous carbohydrate availability blunts ketone formation when the T2 enzyme is insufficient for ketone handling. orpha.net+1

3. Early medical review for vomiting or fever
   Because dehydration and fever accelerate ketone production, prompt evaluation allows timely IV fluids, antiemetics, and acid–base correction. Families are taught to treat any persistent vomiting, tachypnea, fruity breath, or unusual sleepiness as urgent.
   Purpose: Shorten time to treatment and improve outcomes.
   Mechanism: Early stabilization with glucose and fluids prevents severe acidosis and ICU admissions. orpha.net

4. Hydration strategies
   During wellness, maintain adequate fluid intake. During minor illness, use small, frequent sips of glucose-containing fluids; avoid sugar-free oral rehydration while ketotic. In the hospital, isotonic fluids with added dextrose are used.
   Purpose: Support circulation and renal clearance of organic acids.
   Mechanism: Fluids help excrete acids and support perfusion while exogenous glucose turns off ketone generation. orpha.net

5. Emergency letter / metabolic passport
   Families carry a one-page letter explaining the diagnosis and the exact acute protocol (e.g., “start D10% at x mL/kg/h; draw blood gas, glucose, electrolytes”). This reduces delays when presenting to new clinicians.
   Purpose: Speed correct care in any emergency department.
   Mechanism: Standardized instructions trigger early dextrose infusion and acid correction, the proven pillars of acute management. orpha.net

6. Dietary isoleucine moderation (specialist-guided)
   During wellness, most patients tolerate a normal balanced diet; some centers advise mild isoleucine restriction tailored by a metabolic dietitian, especially in those with frequent crises. Strict protein restriction is avoided to prevent malnutrition.
   Purpose: Reduce production of isoleucine-derived organic acids.
   Mechanism: Lower isoleucine intake reduces upstream substrates that contribute to metabolite accumulation when T2 is deficient. orpha.net

7. Illness “carbohydrate-first” rule
   When appetite is poor, offer simple carbohydrate sources first (e.g., juice, oral glucose polymer), then bland protein as tolerated. Fatty foods are delayed until stable.
   Purpose: Quickly suppress ketogenesis.
   Mechanism: Carbohydrate raises insulin and decreases fatty-acid breakdown, limiting ketone body formation. orpha.net

8. Fever control
   Fever increases metabolic rate and catabolism. Use antipyretic measures, cool environment, and fluids.
   Purpose: Limit catabolic drive during infections.
   Mechanism: Lowering temperature reduces energy demand and stress hormone–mediated lipolysis. orpha.net

9. Respiratory support when needed
   Severe acidosis can cause fast, deep breathing and fatigue. Temporary oxygen or ventilatory support may be required in ICU cases.
   Purpose: Maintain oxygenation and reduce work of breathing during crises.
   Mechanism: Stabilizes gas exchange while metabolic treatment reverses acidosis. PubMed Central

10. Electrolyte monitoring and replacement
    Correct potassium, sodium, phosphate, and magnesium based on labs. Safe replacement prevents arrhythmia, weakness, and worsened acidosis.
    Purpose: Normalize physiologic function during decompensation.
    Mechanism: Balanced ions are essential for cardiac and neuromuscular stability and acid–base buffering. orpha.net

11. Acid–base monitoring with blood gases
    Serial blood gases guide bicarbonate therapy and rate of dextrose infusion.
    Purpose: Track severity and recovery from metabolic acidosis.
    Mechanism: Objective pH and bicarbonate levels direct titration of alkali and glucose. orpha.net

12. Education for daycare/school
    Care plans explain snacks, fast response to vomiting, and when to call parents or emergency services.
    Purpose: Reduce fasting risks and delays in care outside the home.
    Mechanism: Non-medical caregivers recognize early signs and follow the written protocol. orpha.net

13. Vaccination on schedule
    Routine vaccines prevent infections that often trigger crises.
    Purpose: Cut illness-related decompensations.
    Mechanism: Fewer infections → fewer catabolic episodes and ER visits. orpha.net

14. Regular metabolic clinic follow-up
    Scheduled reviews adjust dietary plans, check growth, and revisit the emergency protocol.
    Purpose: Keep prevention up to date and detect new issues early.
    Mechanism: Ongoing specialist input is linked to better control in inborn errors of metabolism. orpha.net

15. Newborn and sibling testing
    At-risk siblings can be tested early so families start prevention from birth.
    Purpose: Avoid first severe crisis by early planning.
    Mechanism: Genetic confirmation supports proactive feeding and fast response protocols. MedlinePlus

16. Nutritionist-guided growth support
    Ensure adequate calories and micronutrients; avoid unnecessary protein restriction.
    Purpose: Promote normal growth and reduce illness vulnerability.
    Mechanism: Good nutrition lessens catabolic stress and supports immune health. orpha.net

17. Home ketone awareness
    Families are taught that fruity breath, rapid breathing, and vomiting suggest ketosis; some use urine ketone strips when advised by their team.
    Purpose: Trigger early carbohydrate intake or hospital visit.
    Mechanism: Recognizing early ketosis prevents severe acidosis. orpha.net

18. Hospital care pathways
    Hospitals adopt a standardized order set (labs, D10% infusion rate, electrolyte targets, antiemetic, bicarbonate thresholds).
    Purpose: Reduce variation and delays.
    Mechanism: Pathways accelerate critical steps known to reverse metabolic decompensation. orpha.net

19. Psychosocial support and training
    Teach caregivers simple language about the condition, role-play the sick-day plan, and address anxiety.
    Purpose: Improve adherence to prevention measures.
    Mechanism: Skills training increases confidence and timely action. orpha.net

20. Medical ID bracelet
    Lists the diagnosis and “requires IV dextrose, avoid fasting.”
    Purpose: Alert responders instantly.
    Mechanism: Prompts correct first steps even if the caregiver is not present. orpha.net

---

Drug treatments

There are no FDA-approved drugs that correct the enzyme defect itself. In practice, clinicians use supportive medications during metabolic decompensation. Below are commonly used agents with evidence from FDA labels and metabolic care references. Doses must be individualized by clinicians.

1. Dextrose Injection (D5%–D10% and higher concentrations as needed)
   Class: Parenteral carbohydrate.
   Typical hospital use: D10% continuous infusion titrated by weight and labs; higher concentrations via central access if required.
   When: At any sign of decompensation or poor intake.
   Purpose/Mechanism: Supplies immediate glucose, increases insulin, and shuts down ketone production.
   Adverse effects: Hyperglycemia, fluid overload if not monitored.
   Evidence source: FDA prescribing information for dextrose injections. FDA Access Data+1

2. 0.9% Sodium Chloride (Normal Saline)
   Class: Isotonic crystalloid.
   Use: Resuscitation and maintenance with added dextrose/electrolytes as ordered.
   Purpose/Mechanism: Restores intravascular volume and supports renal acid excretion.
   Adverse effects: Hypernatremia, fluid overload; monitor in renal impairment.
   Evidence source: FDA label. FDA Access Data+1

3. Sodium Bicarbonate (IV)
   Class: Systemic alkalinizing agent.
   Use: For severe metabolic acidosis under specialist guidance (based on blood gases).
   Purpose/Mechanism: Buffers hydrogen ions and raises serum bicarbonate, improving pH and perfusion.
   Adverse effects: Hypernatremia, hypokalemia, volume overload; use with monitoring.
   Evidence source: FDA labeling/PI. U.S. Food and Drug Administration+1

4. Regular Insulin (IV) when needed
   Class: Short-acting insulin.
   Use: Selected cases with marked hyperglycemia or to suppress lipolysis under ICU protocols.
   Purpose/Mechanism: Drives glucose into cells, reducing ketogenesis.
   Adverse effects: Hypoglycemia, hypokalemia; careful titration and dextrose co-infusion required.
   Evidence source: FDA label for Humulin R. FDA Access Data+1

5. Levocarnitine (IV/PO)
   Class: Carnitine supplement (drug form).
   Use: When secondary carnitine deficiency is present or suspected.
   Purpose/Mechanism: Replenishes carnitine to aid fatty-acid transport and removal of acyl groups; may help detoxify accumulating organic acids.
   Adverse effects: GI upset, fishy odor; IV forms can cause infusion reactions.
   Evidence source: FDA-approved labeling for levocarnitine/Carnitor for inborn errors with secondary carnitine deficiency. FDA Access Data+2FDA Access Data+2

6. Ondansetron (IV/PO/ODT)
   Class: 5-HT3 antagonist antiemetic.
   Use: Persistent vomiting to maintain oral/enteral glucose intake and hydration.
   Purpose/Mechanism: Blocks serotonin receptors in the gut/brain to reduce nausea/vomiting.
   Adverse effects: Constipation, QT prolongation (dose-related).
   Evidence source: FDA labels (Zofran). FDA Access Data+2FDA Access Data+2

7. Potassium Chloride (IV/PO)
   Class: Electrolyte replacement.
   Use: Hypokalemia during treatment (especially if insulin is given).
   Purpose/Mechanism: Restores normal cardiac and muscular function.
   Adverse effects: Infusion irritation/arrhythmia if given too rapidly; central line for concentrated solutions.
   Evidence source: FDA labels. FDA Access Data+2FDA Access Data+2

8. Phosphate replacement (e.g., potassium phosphate IV)
   Class: Electrolyte replacement.
   Use: Hypophosphatemia during refeeding or prolonged acidosis.
   Purpose/Mechanism: Restores ATP production and 2,3-DPG in red cells.
   Adverse effects: Hypocalcemia, metastatic calcification if excessive.
   Evidence source: Standard electrolyte replacement is included within FDA-labeled parenteral phosphate products; prescribe per institutional protocols. FDA Access Data

9. Magnesium sulfate (IV)
   Class: Electrolyte replacement.
   Use: Correct documented hypomagnesemia which worsens arrhythmias and hypokalemia.
   Purpose/Mechanism: Cofactor in many enzymes and stabilizes cardiac conduction.
   Adverse effects: Hypotension with rapid infusion.
   Evidence source: FDA-labeled magnesium sulfate is used widely for electrolyte correction (refer to institutional PI). FDA Access Data

10. Sodium citrate/citric acid (oral alkali)
    Class: Oral alkalinizing solution.
    Use: Selected patients for maintenance of acid–base balance between crises if prescribed.
    Purpose/Mechanism: Converts to bicarbonate in the liver, providing a gentler alkali source.
    Adverse effects: GI upset; sodium load.
    Evidence source: FDA SPL data for sodium citrate/citric acid products. FDA Access Data+1

11. Oral dextrose gel / glucose tablets
    Class: Oral carbohydrate.
    Use: Home or hospital use to rapidly provide glucose when mild symptoms begin.
    Purpose/Mechanism: Raises blood glucose and insulin to suppress ketogenesis.
    Adverse effects: Hyperglycemia if excessive.
    Evidence source: Dextrose products are FDA-regulated; see dextrose labeling. FDA Access Data

12. Acetaminophen for fever
    Class: Analgesic/antipyretic.
    Use: Control fever to reduce metabolic stress.
    Purpose/Mechanism: Lowers hypothalamic set point, decreasing metabolic demand.
    Adverse effects: Hepatotoxicity if overdosed; dose by weight.
    Evidence source: FDA-labeled antipyretics are standard in acute care (refer to PI). FDA Access Data

13. Proton-pump inhibitor or H2 blocker when stress gastritis suspected
    Class: Acid suppression.
    Use: Short courses during ICU care if indicated.
    Purpose/Mechanism: Reduce gastric acid injury and vomiting triggers.
    Adverse effects: Headache, diarrhea; avoid prolonged unnecessary use.
    Evidence source: FDA-approved labels for PPIs/H2 blockers (use per clinician judgment). FDA Access Data

14. Antibiotics for intercurrent infections (as indicated)
    Class: Antibacterial agents.
    Use: Treat the infection that precipitated the crisis; selection guided by source and local protocols.
    Purpose/Mechanism: Remove catabolic trigger.
    Adverse effects: Drug-specific.
    Evidence source: FDA-approved antibiotics per diagnosis; not disease-specific to ACAT1 deficiency. FDA Access Data

15. Thiamine (vitamin B1) when nutritional risk is suspected
    Class: Vitamin (cofactor).
    Use: Selected cases with malnutrition risk; not a disease-specific therapy.
    Purpose/Mechanism: Supports carbohydrate metabolism during high-glucose therapy.
    Adverse effects: Rare.
    Evidence source: NIH ODS thiamin fact sheet. Office of Dietary Supplements

16. Riboflavin (vitamin B2) when dietary insufficiency is suspected
    Class: Vitamin (cofactor).
    Use: General mitochondrial cofactor support in nutritional risk; not disease-specific.
    Purpose/Mechanism: Supports redox reactions in energy metabolism.
    Adverse effects: Benign yellow urine.
    Evidence source: NIH ODS riboflavin fact sheet. Office of Dietary Supplements

17. Oral rehydration with carbohydrate-containing solutions
    Class: Balanced oral fluids with glucose and electrolytes.
    Use: Mild illness at home if not vomiting.
    Purpose/Mechanism: Provides water, salts, and carbohydrate to blunt ketosis.
    Adverse effects: Caution with sugar-free formulas during ketosis.
    Evidence source: Composition principles overlap with FDA-regulated electrolyte solutions; follow clinician guidance. FDA Access Data

18. IV multivitamins in prolonged NPO patients
    Class: Parenteral vitamins.
    Use: ICU or prolonged NPO situations to avoid deficiency.
    Purpose/Mechanism: Maintain cofactors during high-glucose therapy.
    Adverse effects: Rare infusion reactions.
    Evidence source: FDA-labeled parenteral multivitamin products per institutional protocol. FDA Access Data

19. Antipyretic rotation only if clinically appropriate
    Class: Analgesics/antipyretics.
    Use: If fever persists and clinician recommends.
    Purpose/Mechanism: Reduce catabolic stress.
    Adverse effects: Drug-specific; avoid NSAIDs if dehydration or renal risk.
    Evidence source: FDA labeling for antipyretic agents guides dosing/risks. FDA Access Data

20. Careful avoidance of lactated Ringer’s in severe lactic acidosis
    Class: IV fluids selection principle.
    Use: Prefer dextrose-containing isotonic saline early in crisis.
    Purpose/Mechanism: Focus on glucose delivery; avoid added lactate load when severely acidotic.
    Adverse effects: N/A when LR avoided.
    Evidence source: Acute metabolic care references emphasize glucose-first, saline-based resuscitation. orpha.net

Note: Medication names above are drawn from FDA labels; indications in ACAT1 deficiency are supportive/off-label. Always treat under specialist supervision. FDA Access Data+3FDA Access Data+3FDA Access Data+3

---

Dietary molecular supplements

These are sometimes discussed as adjuncts to good nutrition; none replace acute glucose/alkali therapy. Doses are typical ranges from federal fact sheets or clinical references; individualize with clinicians.

1. L-carnitine (oral) – 50–100 mg/kg/day divided; adults often 1–3 g/day
   Function/Mechanism: Transports long-chain fatty acids into mitochondria and may help remove acyl groups; supports energy use during stress. Evidence in ACAT1 is limited; use when deficiency is present. Office of Dietary Supplements

2. Thiamine (vitamin B1) – usual adult 1–2 mg/day (higher repletion in deficiency)
   Function/Mechanism: Coenzyme for carbohydrate metabolism; helps use the high-glucose infusion safely. Office of Dietary Supplements

3. Riboflavin (vitamin B2) – adult RDA ~1.1–1.3 mg/day; higher if advised
   Function/Mechanism: Flavin coenzymes (FAD/FMN) support redox reactions in energy pathways. Office of Dietary Supplements

4. Coenzyme Q10 – common supplemental range 100–300 mg/day (varies)
   Function/Mechanism: Electron carrier in the respiratory chain and antioxidant; supportive for mitochondrial function (not ACAT1-specific). NCCIH+1

5. Alpha-lipoic acid – often 300–600 mg/day in adult studies
   Function/Mechanism: A mitochondrial cofactor with antioxidant effects; theoretical support for redox balance. Use cautiously and with clinician oversight. NCBI+1

6. Omega-3 fatty acids (EPA/DHA) – dietary intake or supplements per clinician
   Function/Mechanism: Anti-inflammatory lipid mediators; general cardiometabolic support. Not disease-specific. Office of Dietary Supplements

7. General multivitamin/mineral – age-appropriate RDA coverage
   Function/Mechanism: Prevents deficits that increase catabolic risk during illness. Office of Dietary Supplements

8. Biotin – only if deficiency risk; follow standard dosing
   Function/Mechanism: Carboxylase cofactor; general fatty-acid and glucose metabolism support. Office of Dietary Supplements

9. Vitamin D – replete if low per guideline labs
   Function/Mechanism: Immune and musculoskeletal support; reduces illness susceptibility. Office of Dietary Supplements

10. Probiotics/fermented foods – dietary approach as advised
    Function/Mechanism: May reduce GI illness frequency, indirectly lowering crisis triggers; strain-specific evidence varies. Office of Dietary Supplements

---

Immunity-support / regenerative / stem-cell drugs

There are no approved “immunity booster,” regenerative, or stem-cell drugs for ACAT1 deficiency. Management relies on prevention, glucose, and correction of acidosis. Below are six concepts clinicians consider in complex cases, but they are not disease-specific approvals:

1. Levocarnitine (drug form) – supports detoxification when secondary deficiency exists; adjunct only. FDA Access Data

2. Thiamine – cofactor support during intensive glucose therapy if nutritional risk is suspected. Office of Dietary Supplements

3. Riboflavin – redox cofactor support when dietary intake is uncertain. Office of Dietary Supplements

4. Coenzyme Q10 (supplement) – mitochondrial electron transport support; not curative. NCCIH

5. Alpha-lipoic acid (supplement) – antioxidant cofactor; evidence base is general mitochondrial support, not ACAT1-specific. NCBI

6. Nutritional immunization (vaccines per schedule) – reduces infection-triggered crises; not a “drug” for ACAT1 but a key preventive medical intervention. orpha.net

---

Surgeries or procedures

1. Central venous catheter placement – when high-concentration dextrose or electrolyte infusions are needed and peripheral access is inadequate. Why: Safe delivery of hypertonic glucose/electrolytes to reverse ketosis. FDA Access Data

2. Endotracheal intubation and mechanical ventilation – in severe coma or respiratory fatigue from deep Kussmaul breathing. Why: Maintain oxygenation/ventilation while correcting acidosis. PubMed Central

3. Nasogastric tube for continuous carbohydrate feeds – if oral intake fails but ventilation is intact. Why: Provide steady carbohydrate to suppress ketogenesis. orpha.net

4. Arterial/venous lines for frequent labs – facilitate close acid–base and electrolyte monitoring in ICU. Why: Guide precise titration of alkali and electrolytes. orpha.net

5. Renal replacement therapy (rare) – in refractory, life-threatening acidosis or renal failure. Why: Rapid acid and toxin removal when standard care is insufficient. orpha.net

---

Preventions

1. Never skip meals; add bedtime snacks. Reason: Avoid fasting-induced ketosis. orpha.net

2. Start oral glucose early during illness. Reason: Blunt ketone production. orpha.net

3. Have an emergency letter and supplies ready (glucose gel, thermometer). Reason: Speed care. orpha.net

4. Keep vaccinations up to date. Reason: Fewer infection triggers. orpha.net

5. Stay well hydrated. Reason: Helps kidneys clear acids. orpha.net

6. See a metabolic clinic regularly. Reason: Update sick-day plans and nutrition. orpha.net

7. Educate school/caregivers. Reason: Quick action if symptoms start. orpha.net

8. Treat fever and infections fast. Reason: Reduce catabolic stress. orpha.net

9. Carry medical ID. Reason: Guides emergency responders. orpha.net

10. Avoid long strenuous activity without carbs. Reason: Prevents exercise-induced catabolism. orpha.net

---

When to see a doctor urgently

Seek urgent care immediately for: repeated vomiting; fast or deep breathing; fruity breath; unusual sleepiness or confusion; inability to keep fluids down; fever not settling; or signs of dehydration (dry mouth, no tears, little urine). These can be early signs of a ketoacidotic attack and need IV dextrose and monitoring. MedlinePlus+1

---

What to eat and what to avoid

What to eat:

1. Regular meals with balanced carbohydrates;

2. Extra carbohydrates during illness;

3. Fruits and grains as tolerated;

4. Lean protein in modest portions guided by your dietitian;

5. Dairy or alternatives for calories;

6. Easily digestible carbs (toast, rice, bananas) during recovery;

7. Oral glucose polymers when advised;

8. Plenty of water and allowed electrolyte drinks;

9. Bedtime snack (carb-containing);

10. Vitamin-rich foods to maintain general health. orpha.net

What to avoid:

1. Long fasting;

2. Skipping breakfast;

3. Starting “keto” or very-low-carb diets;

4. Heavy fatty meals during illness;

5. Unsupervised high-protein restriction;

6. Sugar-free electrolyte drinks when ketotic;

7. Excessive exercise without carb intake;

8. Delaying medical review for vomiting;

9. Self-treating severe acidosis at home;

10. Unverified supplements without clinician input. orpha.net

---

Frequently asked questions

1) Is there a cure?
There is no enzyme-replacing drug yet. Good prevention and fast crisis treatment allow many children to grow and learn well. PubMed Central

2) Why do attacks happen during illness?
Illness and fasting push the body to burn fat and make ketones. Because the enzyme is weak, ketones and isoleucine metabolites build up and cause acidosis. orpha.net

3) What is the most important step in a crisis?
Start glucose quickly (oral if mild, IV if moderate/severe) and correct acidosis and fluids in hospital. orpha.net

4) Does carnitine help?
If tests show low carnitine, supplementation can help detoxify acyl groups. It is not a cure and should be prescribed by specialists. FDA Access Data

5) Can my child fast overnight?
Avoid long overnight fasts—use a bedtime snack and follow your clinic’s plan. orpha.net

6) What tests confirm the diagnosis?
Urine organic acids showing isoleucine-derived metabolites plus ACAT1 gene testing. PubMed Central+1

7) Will my child outgrow it?
The genetic enzyme problem persists, but crises can become less frequent with good prevention. orpha.net

8) Are vaccines safe?
Yes. Vaccines are recommended; preventing infections prevents crises. orpha.net

9) Is a low-protein diet required?
Most people eat a balanced diet; strict protein restriction is avoided. Some centers consider mild isoleucine moderation under a dietitian. orpha.net

10) What happens during hospital treatment?
IV dextrose and electrolytes, antiemetics, and sometimes bicarbonate if acidosis is severe; frequent labs guide therapy. FDA Access Data+2FDA Access Data+2

11) Are there adult cases?
Yes—some adults are diagnosed after years, sometimes with diabetes or unusual presentations. BioMed Central

12) Can exercise trigger an attack?
Hard exercise without carbs can increase ketones; use carbohydrate before/during as advised. orpha.net

13) Is genetic counseling helpful?
Yes. It explains carrier risks and options for testing siblings or future pregnancies. MedlinePlus

14) Which specialists manage this condition?
Metabolic geneticists, metabolic dietitians, pediatricians, and ICU teams during crises. orpha.net

15) Where can I read more?
Authoritative summaries are available from Orphanet, MedlinePlus Genetics, and peer-reviewed reviews on ACAT1 deficiency. orpha.net+2MedlinePlus+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 23, 2025.

PDF Documents For This Disease Condition References